Cover Image
市場調查報告書

rEVO Biologics, Inc.的產品平台分析

rEVO Biologics, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 337046
出版日期 內容資訊 英文 24 Pages
訂單完成後即時交付
價格
Back to Top
rEVO Biologics, Inc.的產品平台分析 rEVO Biologics, Inc. - Product Pipeline Review - 2015
出版日期: 2015年07月08日 內容資訊: 英文 24 Pages
簡介

rEVO Biologics, Inc. (原GTC Biotherapeutics, Inc.) 是開發,銷售針對罕見疾病用生技藥品的製藥企業。該公司致力於開發重組醫藥品。

本報告提供rEVO Biologics, Inc.的藥劑開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的藥物評估,最新的開發平台趨勢,主要企業廣播等資訊。

rEVO Biologics, Inc.的基本資料

rEVO Biologics, Inc.概要

  • 主要資訊
  • 企業資料

rEVO Biologics, Inc.:R&D概要

  • 主要的治療範圍

rEVO Biologics, Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

rEVO Biologics, Inc.:開發中產品概況

  • 後期開發中產品
    • 第三階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

rEVO Biologics, Inc.:藥物簡介

  • antithrombin alfa (recombinant)
  • LR-769
  • Recombinant Human Alpha-1 Antitrypsin

rEVO Biologics, Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

rEVO Biologics, Inc.:最近的開發平台趨勢

rEVO Biologics, Inc.:企業發表

rEVO Biologics, Inc.:總公司和子公司的所在地

附錄

目錄
Product Code: GMDHC07347CDB

Summary

Global Markets Direct's, 'rEVO Biologics, Inc. - Product Pipeline Review - 2015', provides an overview of the rEVO Biologics, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of rEVO Biologics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of rEVO Biologics, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of rEVO Biologics, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the rEVO Biologics, Inc.'s pipeline products

Reasons to buy

  • Evaluate rEVO Biologics, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of rEVO Biologics, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the rEVO Biologics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of rEVO Biologics, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of rEVO Biologics, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of rEVO Biologics, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • rEVO Biologics, Inc. Snapshot
    • rEVO Biologics, Inc. Overview
    • Key Information
    • Key Facts
  • rEVO Biologics, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • rEVO Biologics, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • rEVO Biologics, Inc. - Pipeline Products Glance
    • rEVO Biologics, Inc. - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • rEVO Biologics, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • rEVO Biologics, Inc. - Drug Profiles
    • antithrombin alfa (recombinant)
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • LR-769
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Recombinant Human Alpha-1 Antitrypsin
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • rEVO Biologics, Inc. - Pipeline Analysis
    • rEVO Biologics, Inc. - Pipeline Products by Target
    • rEVO Biologics, Inc. - Pipeline Products by Route of Administration
    • rEVO Biologics, Inc. - Pipeline Products by Molecule Type
    • rEVO Biologics, Inc. - Pipeline Products by Mechanism of Action
  • rEVO Biologics, Inc. - Recent Pipeline Updates
  • rEVO Biologics, Inc. - Company Statement
  • rEVO Biologics, Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • rEVO Biologics, Inc., Key Information
  • rEVO Biologics, Inc., Key Facts
  • rEVO Biologics, Inc. - Pipeline by Indication, 2015
  • rEVO Biologics, Inc. - Pipeline by Stage of Development, 2015
  • rEVO Biologics, Inc. - Monotherapy Products in Pipeline, 2015
  • rEVO Biologics, Inc. - Phase III, 2015
  • rEVO Biologics, Inc. - Preclinical, 2015
  • rEVO Biologics, Inc. - Pipeline by Target, 2015
  • rEVO Biologics, Inc. - Pipeline by Route of Administration, 2015
  • rEVO Biologics, Inc. - Pipeline by Molecule Type, 2015
  • rEVO Biologics, Inc. - Pipeline Products by Mechanism of Action, 2015
  • rEVO Biologics, Inc. - Recent Pipeline Updates, 2015
  • rEVO Biologics, Inc., Subsidiaries

List of Figures

  • rEVO Biologics, Inc. - Pipeline by Top 10 Indication, 2015
  • rEVO Biologics, Inc. - Pipeline by Stage of Development, 2015
  • rEVO Biologics, Inc. - Monotherapy Products in Pipeline, 2015
  • rEVO Biologics, Inc. - Pipeline by Top 10 Target, 2015
  • rEVO Biologics, Inc. - Pipeline by Top 10 Molecule Type, 2015
  • rEVO Biologics, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top